Seegene

Seegene, Inc. is an in vitro diagnostic (IVD) company that transforms concepts into products through groundbreaking R&D activities. Founded in Seoul in 2000, with subsidiaries in Rockville, Maryland, USA, and Eschborn, Germany, Seegene has developed innovative technology platforms™ including ACP (Activated Chemiluminescent Probe), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection). With these advanced molecular diagnostic (MoDx) technologies applied to diagnostic kits and other tools, Seegene elevates the sensitivity and specificity of PCR (Polymerase Chain Reaction) to unprecedented levels. Seegene offers multiplex PCR products capable of simultaneously targeting and detecting multiple pathogens' genes, saving testing time and costs. Seegene will continue to set new standards in MoDx and deliver innovative, cost-effective solutions.